E&O Laboratories Ltd.

Group B Streptococcus (GBS), also known as Streptococcus agalactiae, is the leading cause of severe illness, long term health issues, and mortality in infants. Studies indicate that approximately 12-27% of pregnant women are colonised by Group B Strep(1). Detection and treatment of vaginal (and in some countries also rectal) colonisation by GBS in pregnant women is the most effective strategy to prevent infection transmission during labour. Screening women for GBS helps doctors determine whether intrapartum antibiotic prophylaxis is required, which can prevent early onset GBS infections(2). PP1089 Group B Streptococcus (GBS) Medium, based on a formulation set out by de la Rosa et al(1) is a selective medium for the detection and differentiation of haemolytic group B streptococci (GBS) from clinical samples.  As pictured, when cultured on PP1089 GBS Medium, -haemolytic GBS strains form very obvious orange pigmented colonies in the absence of oxygen, whereas other species form grey/colourless colonies or are completely inhibited, making differentiation incredibly easy. E&O also offer BM1956-M055-3 LIM Broth, an enrichment broth for Group B Strep samples, available in a polypropylene transport tube and SW0005-Group B Strep Swab Kit, for sampling, transport and enrichment of potential GBS samples. The kit contains a sterile swab for sampling and tube of BM1956 LIM Broth for sample transport and enrichment.  To order please contact your E&O Account Manager, or email enquiries@eolabs.com. For more information, the product's Instructions for Use (IFU) and Material Safety Data Sheet (MSDS) please visit: https://lnkd.in/erra7TrC #eolabs #GBS #GroupBStrep #StreptococcusAgalactiae #MicrobiologyDiagnostics References: Hanna M, Noor A. Streptococcus Group B. [Updated 2023 Jan 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://lnkd.in/evUxVYgu 2. Public Health England (2018) Detection of Carriage of Group B Streptococci (Streptococcus agalactiae). UK Standards for Microbiology Investigations. Bacteriology, B 58(3.1). London: Standards Unit, Microbiology Services. 3. de la Rosa, M., Perez, M., Carazo, C., Pareja, L., Peis, J. I., and Hernandez, F. (1992) New Granada Medium for detection and identification of group B streptococci. Journal of clinical microbiology, 30(4), pp.1019–1021.

Group B Streptococcus (GBS), also known as Streptococcus agalactiae, is the leading cause of severe illness, long term health issues, and mortality in infants. Studies indicate that approximately 12-27% of pregnant women are colonised by Group B Strep(1). Detection and treatment of vaginal (and in some countries also rectal) colonisation by GBS in pregnant women is the most effective strategy to prevent infection transmission during labour. Screening women for GBS helps doctors determine whether intrapartum antibiotic prophylaxis is required, which can prevent early onset GBS infections(2). PP1089 Group B Streptococcus (GBS) Medium, based on a formulation set out by de la Rosa et al(1) is a selective medium for the detection and differentiation of haemolytic group B streptococci (GBS) from clinical samples.  As pictured, when cultured on PP1089 GBS Medium, -haemolytic GBS strains form very obvious orange pigmented colonies in the absence of oxygen, whereas other species form grey/colourless colonies or are completely inhibited, making differentiation incredibly easy. E&O also offer BM1956-M055-3 LIM Broth, an enrichment broth for Group B Strep samples, available in a polypropylene transport tube and SW0005-Group B Strep Swab Kit, for sampling, transport and enrichment of potential GBS samples. The kit contains a sterile swab for sampling and tube of BM1956 LIM Broth for sample transport and enrichment.  To order please contact your E&O Account Manager, or email enquiries@eolabs.com. For more information, the product's Instructions for Use (IFU) and Material Safety Data Sheet (MSDS) please visit: https://lnkd.in/erra7TrC #eolabs #GBS #GroupBStrep #StreptococcusAgalactiae #MicrobiologyDiagnostics References: Hanna M, Noor A. Streptococcus Group B. [Updated 2023 Jan 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://lnkd.in/evUxVYgu 2. Public Health England (2018) Detection of Carriage of Group B Streptococci (Streptococcus agalactiae). UK Standards for Microbiology Investigations. Bacteriology, B 58(3.1). London: Standards Unit, Microbiology Services. 3. de la Rosa, M., Perez, M., Carazo, C., Pareja, L., Peis, J. I., and Hernandez, F. (1992) New Granada Medium for detection and identification of group B streptococci. Journal of clinical microbiology, 30(4), pp.1019–1021.

Medlab Middle East 2025 is almost here. Neil Pointon (Exports Sales Manager) and Dr Douglas Cameron (Technical Manager) are excited to meet you to talk about E&O Exports.

Detect & differentiate 𝘊𝘢𝘯𝘥𝘪𝘥𝘢 𝘢𝘶𝘳𝘪𝘴 and other 𝘊𝘢𝘯𝘥𝘪𝘥𝘢 spp. with Colorex™ Candida Plus. First identified in 2009 in Japan, Candida auris has since been identified across the globe in over 40 countries, with the WHO grading 𝘊. 𝘢𝘶𝘳𝘪𝘴 as a “critical priority pathogen”. (1) 𝘊𝘢𝘯𝘥𝘪𝘥𝘢 𝘢𝘶𝘳𝘪𝘴 causes bloodstream infections and also infects bones, CSF, and intra-abdominal areas. The pathogen has been isolated from wounds, ears, respiratory tract, urine, bile, and jejunal tissue. Affecting adults and children, 𝘊. 𝘢𝘶𝘳𝘪𝘴 spreads in high-risk healthcare settings via shared use equipment and environments. High colonisation rates are particularly noted in long-term care facilities providing ventilator support. This ease of transmission emphasises the need for robust infection prevention and control (IPC) strategies, including screening. (2) CHROMagar’s ColorexTM Candida Plus (E&O Product code PP3018-P090), has been developed for the rapid identification and differentiation of 𝘊. 𝘢𝘶𝘳𝘪𝘴 (3) and other major clinical 𝘊𝘢𝘯𝘥𝘪𝘥𝘢 spp. • Ideally suited for screening patients suspected of being colonised or infected with 𝘊. 𝘢𝘶𝘳𝘪𝘴 • Detection in 36 hrs vs 60 hrs for Sabouraud Dextrose Agar & Chloramphenicol (SABC) • Growth rate and recovery of 𝘊. 𝘢𝘶𝘳𝘪𝘴 from pure/mixed cultures is substantially greater vs SABC • Rapid differentiation of 𝘊. 𝘢𝘶𝘳𝘪𝘴 from a wide range of other yeast species • Allows for more targeted colony selection for further confirmation When cultured using Colorex™ Candida Plus, 𝘊. 𝘢𝘶𝘳𝘪𝘴 produces distinctive colony characteristics compared to other common Candida species: • 𝘊. 𝘢𝘶𝘳𝘪𝘴: blue colonies with blue halo, blue colonies from reverse side of plate • 𝘊. 𝘢𝘭𝘣𝘪𝘤𝘢𝘯𝘴: green-blue colonies • 𝘊. 𝘵𝘳𝘰𝘱𝘪𝘤𝘢𝘭𝘪𝘴: metallic blue colonies with pink halo • 𝘊. 𝘬𝘳𝘶𝘴𝘦𝘪: pink fuzzy colonies • 𝘊. 𝘨𝘭𝘢𝘣𝘳𝘢𝘵𝘢: mauve colonies PP3018-P090 Colorex™ Candida Plus comes ready-to-use in packs of 10 with a shelf life of 70 days from manufacture. For more information, download the Colorex™ Candida Plus IFU: PP3018-IFU-Rev-01.pdf To order please contact your E&O Account Manager, or email enquiries@eolabs.com. Prepared media plates made with CHROMagar™ powder are available in several countries under Colorex™ and RambaCHROM™ trademarks. References 1) https://lnkd.in/dinPtUDq 2) https://lnkd.in/gTWyyN9M 3) https://lnkd.in/emPQ-Qf2 #CandidaAuris #HealthcareInnovation #InfectionControl #MedicalMicrobiology #LaboratoryDiagnostics #eolabs

Medica 2024 - Day 4. With the exhibition winding down, it's now your last chance to see our team in Düsseldorf. Come to our stand and say hello - we're in Hall 1, Stand A60.

On October 30th, the UKHSA announced the detection of the first mpox Clade 1b case in the UK, followed in the subsequent days by three additional cases arising from the same household in London. (1) The World Health Organization declared mpox (MPXV) a public health emergency of international concern, following outbreaks in the Democratic Republic of Congo and other African nations (2), with subsequent outbreaks detected in Thailand, Germany, Sweden, and India (3)(4). For mpox sample collection and transport, E&O Laboratories produces Molecular Sampling Solution (MSS), a reagent formulated and validated for the inactivation and transportation of specimens potentially containing a wide range of viral and bacterial pathogens, including mpox. MSS is designed to disrupt microorganisms, denature proteins and nucleases and facilitate transportation of viral samples at refrigerated and room temperatures prior to testing. Viral nucleic acids remain stable in MSS at room temperature for at least 14 days. By using MSS, infection hazard is reduced during transport and laboratory processing whilst preserving nucleic acids for identification by PCR or other nucleic acid techniques. MSS has a shelf life of 2 years from manufacture. MSS transport tubes are also compatible and validated for use with automated laboratory platforms. MSS is available in the following products:- 𝗦𝗪𝟬𝟬𝟬𝟰-𝗠𝟬𝟰𝟯-𝟮 𝗠𝗦𝗦 𝗦𝘄𝗮𝗯 𝗞𝗶𝘁 Comprises a transport tube of MSS (2ml fill) with red swab-capture cap, and a sterile small viscose tipped polystyrene swab with 78mm break-point, all encapsulated in an easy-peel pouch. The swab may be used to collect samples from areas including (but not limited to) the skin, nose, throat, anus and vagina. The swab is not suitable for nasopharyngeal sampling. 100 kits per box. 𝗕𝗠𝟭𝟲𝟳𝟳-𝗠𝟬𝟰𝟯-𝟮 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻 (𝗠𝗦𝗦) Tray pack of 50 red-capped MSS tubes with 2ml fill. MSS Flyer https://lnkd.in/eZjCRZPS Swab Kit Instructions for Use (IFU) https://lnkd.in/eB2pS3ip BM1677 Instructions for Use (IFU) https://lnkd.in/emiG4EBs To order please contact your E&O Account Manager, or email enquiries@eolabs.com. References: 1.           https://lnkd.in/eZzRfGAw 2.          https://lnkd.in/e8jYWZxe 3.          https://lnkd.in/enrpyfDH 4.          https://lnkd.in/eXgXnvdB #eolabs #MPXV #GlobalHealth #samplecollection #WHO

We'll be exhibiting at Messe Düsseldorf for Medica 2024. Come to our stand (Hall 1 / A60) to meet the E&O team: Neil Pointon (Export Account Manager), Richard Flynn (UK Sales Manager), Douglas Cameron (Technical Manager), and Raj Dhami (Business Development Manager and Senior Account Manager). To arrange a meeting please contact: Neil Pointon (Export Account Manager) Call +44 (0) 7545 210 963 https://lnkd.in/eW_Qn6SS Richard Flynn (UK Sales Manager): Call +44 (0) 7936 371 975 https://lnkd.in/edgRWiPK Dr Douglas Cameron PhD BSc (Hons) (Technical Manager): Call +44 (0) 7736 161 999 https://lnkd.in/e2-sJp4D   Raj Dhami (Senior Key Account Manager / Business Development Manager): Call +44 (0) 7764 511 087 https://lnkd.in/eGDEJaVW #eolabs #MEDICA2024 #MesseDüsseldorf #MedTech #MedicalIndustry #HealthTech

🌟 Congratulations to the brilliant Sana Tansey - MSc of the Department of Medical Microbiology at Galway University Hospitals for receiving a distinction ribbon for her outstanding poster presentation on 'The Verification of EUCAST Antibicrobial Susceptibility Testing for Anaerobes in Disk Diffusion' during #LabCon2024! 👏 E&O Laboratories Ltd.'s Fastidious Anaerobic Agar with 5% Defibrinated Hosre Blood (code PP1564), provided by Syntec Group, played a key role in verifying the newly released EUCAST methodology and breakpoints for AST of anaerobic bacteria. 🏆 Key Achievement: The implementation of this method has significantly reduced the turnaround time for AST results—from 14 days to just 24 hours! This method has now been adopted for routine use in the Department of Medical Microbiology at GUH, enhancing patient care. If you have any questions on the FAAw5%HB (code PP1564) media used, or would like to try some of this media out in your lab, please get in touch 📧 sales@syntec.ie . Thanks again to The Academy of Clinical Science and Laboratory Medicine for organizing such a fantastic event! #AntibicrobialSusceptibilityTesting #MedicalMicrobiology #AnaerobicBacteria #FastidiousAnaerobicAgar #PatientsFirst #CultureMedia

𝗘&𝗢 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀 𝗼𝗳𝗳𝗲𝗿 𝗮 𝘄𝗶𝗱𝗲 𝗿𝗮𝗻𝗴𝗲 𝗼𝗳 𝗿𝗲𝗮𝗴𝗲𝗻𝘁𝘀 𝘁𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝘁𝗵𝗲 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗽𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗼𝗳 𝗺𝘆𝗰𝗼𝗯𝗮𝗰𝘁𝗲𝗿𝗶𝗮 𝗮𝗻𝗱 𝘁𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀 (𝗧𝗕) 𝘀𝗮𝗺𝗽𝗹𝗲𝘀. Our range of decontaminants and buffers comprises Oxalic Acid in 5% and 3% concentrations, TB Buffer (pH 4.5), Sodium Hydroxide in 2% and 4% concentrations with or without Phenol Red, Sulphuric Acid (4%), Sputum Neutralising Buffer with or without Phenol Red, and Phosphate Buffer (0.067M). These reagents are available in various containers and fill volumes to suit your required test methodology. Accompanying this range of reagents, we also offer the UK's most comprehensive selection of prepared culture media for the isolation and differentiation of mycobacteria and TB. For more information, download our Media and Reagents for Mycobacteria flyer https://lnkd.in/eNkRTjDc and contact your E&O Account Manager to place an order. #TB #Tuberculosis #mycobacteria #culturemedia #eolabs #reagents #decontaminants #buffers

𝗘&𝗢 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀 𝗽𝗿𝗼𝗱𝘂𝗰𝗲 𝘁𝗵𝗲 𝗨𝗞’𝘀 𝗺𝗼𝘀𝘁 𝗲𝘅𝘁𝗲𝗻𝘀𝗶𝘃𝗲 𝗿𝗮𝗻𝗴𝗲 𝗼𝗳 𝗽𝗿𝗲𝗽𝗮𝗿𝗲𝗱 𝗰𝘂𝗹𝘁𝘂𝗿𝗲 𝗺𝗲𝗱𝗶𝗮 𝗳𝗼𝗿 𝗺𝘆𝗰𝗼𝗯𝗮𝗰𝘁𝗲𝗿𝗶𝗮 𝗮𝗻𝗱 𝘁𝘂𝗯𝗲𝗿𝗰𝘂𝗹𝗼𝘀𝗶𝘀 (𝗧𝗕) 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗶𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻. E&O’s mycobacteria range includes a variety of sloped, plated, and broth culture media, featuring multiple formulations of Lowenstein-Jensen (L.J.), Stonebrinks, and Middlebrook media, designed for the isolation and differentiation of mycobacteria from clinical, veterinary, pharmaceutical, water, and environmental samples. To complement this comprehensive culture media range, we also provide a wide selection of decontamination and buffering reagents used in specimen preparation. Our media is quality controlled in a UKAS accredited laboratory using ISO17025 compliant test methods with first generation NCTC/ATCC reference strains used in quality control procedures. For more information, download our Media and Reagents for Mycobacteria flyer. https://lnkd.in/eNkRTjDc Contact your E&O account manager to place an order. #eolabs #tuberculosis #TB #TBmedia #TBreagents #microbiology #culturemedia #clinical #veterinary #food #water #environmental